Dissolved and financials
CVR: 38750410
DKK 69,519
Gross profit
Net result: DKK -10,984
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 25 January 2022
CVR · view overview
0 employees
CVR · 2018
Director role ended: Søren Aamann Jensen
CVR · 21/01/2021
View the full event history
Crisida IVS was a Danish company of the type Iværksætterselskab based in Rødovre, founded in 2017. The company has been dissolved on 25 January 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 0 employees (2018). In 2018, the company reported a gross profit of DKK 69,519 and a net result of DKK -10,984. Equity in the 2018 report amounted to DKK 8,168.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/01/2018 – 31/12/2018 | 70 t. | -11 t. | 44 t. | 8 t. | 1 |
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorNo. Crisida IVS is registered in the Danish CVR register with the status Dissolved and ceased on 25 January 2022.
The CVR number of Crisida IVS is 38750410.
In 2018, Crisida IVS reported a gross profit of DKK 69,519.
Crisida IVS had 0 employees in 2018 according to the Danish CVR register.
Crisida IVS was founded on 27 June 2017.
Crisida IVS was registered under the industry Konsulentbistand vedrørende informationsteknologi (industry code 620200).
Crisida IVS was dissolved on January 25, 2022.
As of January 21, 2021, Søren Aamann Jensen has stepped down as liquidator of Crisida IVS.
On January 21, 2021, Crisida IVS exited liquidation.
As of December 1, 2020, Søren Aamann Jensen is registered as liquidator of Crisida IVS.
On December 1, 2020, Crisida IVS entered liquidation.
As of October 14, 2020, Søren Kristensen has stepped down as director of Crisida IVS.
Crisida IVS has published its annual report for 2018. Gross profit came to DKK 69,519, and the net result was DKK -10,984.
Crisida IVS has published its interim report for the period June 27, 2017 – December 31, 2017.
As of September 11, 2018, Søren Kristensen is registered as director of Crisida IVS.
As of August 21, 2018, Søren Kristensen has stepped down as adm. dir. of Crisida IVS.
As of June 27, 2017, Søren Kristensen is registered as adm. dir. of Crisida IVS.
Crisida IVS was founded on June 27, 2017.
